Cargando…
A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI
Recent advancements in imaging diagnostics have focused on the use of nanostructures that entrap Magnetic Resonance Imaging (MRI) Contrast Agents (CAs), without the need to chemically modify the clinically approved compounds. Nevertheless, the exploitation of microfluidic platforms for their control...
Autores principales: | Russo, Maria, Bevilacqua, Paolo, Netti, Paolo Antonio, Torino, Enza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128828/ https://www.ncbi.nlm.nih.gov/pubmed/27901092 http://dx.doi.org/10.1038/srep37906 |
Ejemplares similares
-
Commentary on “A Microfluidic Platform to Design Crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for Enhanced MRI”
por: Russo, Maria, et al.
Publicado: (2017) -
A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications
por: Tammaro, Olimpia, et al.
Publicado: (2020) -
Author Correction: A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications
por: Tammaro, Olimpia, et al.
Publicado: (2020) -
Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells
por: Costagliola di Polidoro, Angela, et al.
Publicado: (2021) -
Glycosaminoglycans and Contrast Agents: The Role of Hyaluronic Acid as MRI Contrast Enhancer
por: Ponsiglione, Alfonso Maria, et al.
Publicado: (2020)